COPD: latest insights into the management of patients

Lunchtime session
Chairs: M. Saetta (Padova, PD, Italy), U. Costabel (Essen, Germany)
Aims: The aim of the session is to learn about the latest treatments, clinical developments, and cutting edge research in the area of COPD management and treatment.

Risk biomarkers in COPD: a focus on eosinophils M. Bafadhel (Oxford, United Kingdom)
What does endotyping mean for treatment? A. Agusti Garcia-Navarro (Barcelona, Spain)
Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort M. Han (Ann Arbor, United States of America)